Natural killer cells preferentially target cancer stem cells; role of monocytes in protection against NK cell mediated lysis of cancer stem cells.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Current Drug Delivery

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/156720112798375989PMID 22023212
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myeloid derived suppressor cells in human diseases.

  2011cited by this paper
• The mechanisms of cancer immunoescape and development of overcoming strategies

  2011cited by this paper
• Increased Lysis of Stem Cells but Not Their Differentiated Cells by Natural Killer Cells; De-Differentiation or Reprogramming Activates NK Cells

  2010cited by this paper
• Macrophages, innate immunity and cancer: balance, tolerance, and diversity.

  2010cited by this paper
• Strategies to Rescue Mesenchymal Stem Cells (MSCs) and Dental Pulp Stem Cells (DPSCs) from NK Cell Mediated Cytotoxicity

  2010cited by this paper
• Microanatomy of the liver immune system

  2009cited by this paper
• Tumor-associated macrophages: effectors of angiogenesis and tumor progression.

  2009cited by this paper
• Epidermal Growth Factor Plays a Crucial Role in Mitogenic Regulation of Human Brain Tumor Stem Cells*

  2008cited by this paper
• Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab′)2 fragment of anti-CD16 antibody

  2008cited by this paper
• Potential contribution of naïve immune effectors to oral tumor resistance: role in synergistic induction of VEGF, IL-6, and IL-8 secretion

  2008cited by this paper
• Rebuilding immunity in cancer patients.

  2008cited by this paper
• Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2.

  2008cited by this paper
• Human Leukocyte Antigen‐G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells

  2008cited by this paper
• Long-term maintenance of brain tumor stem cell properties under at non-adherent and adherent culture conditions.

  2007cited by this paper
• Potent induction of TNF-α during interaction of immune effectors with oral tumors as a potential mechanism for the loss of NK cell viability and function

  2007cited by this paper
• VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells.

  2007cited by this paper
• Inhibition of nuclear factor kappa B (NFκB) activity in oral tumor cells prevents depletion of NK cells and increases their functional activation

  2006cited by this paper
• Coengagement of CD16 and CD94 Receptors Mediates Secretion of Chemokines and Induces Apoptotic Death of Naive Natural Killer Cells

  2006cited by this paper
• Emerging Mechanisms of Immunosuppression in Oral Cancers

  2006cited by this paper
• Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125.

  2005cited by this paper
• Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer

  2005cited by this paper
• Human mesenchymal stem cells modulate allogeneic immune cell responses.

  2005cited by this paper
• NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma.

  2005cited by this paper
• The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer.

  2004cited by this paper
• Influence of CpG island methylation status in O6-methylguanine-DNA methyltransferase expression of oral cancer cell lines.

  2004cited by this paper
• Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

  2004cited by this paper
• Cytokines IL-1 alpha, IL-6, and GM-CSF constitutively secreted by oral squamous carcinoma induce down-regulation of CD80 costimulatory molecule expression: restoration by interferon gamma.

  2004cited by this paper
• Characterization of the progressive skin disease and inflammatory cell infiltrate in mice with inhibited NF-kappaB signaling.

  2004cited by this paper
• The immunobiology of cancer immunosurveillance and immunoediting.

  2004cited by this paper
• Nuclear factor-kappaB: the enemy within.

  2004cited by this paper
• Rapid progression from oral leukoplakia to carcinoma in an immunosuppressed liver transplant recipient.

  2003cited by this paper
• Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

  2003cited by this paper
• Cytokine dependent inverse regulation of CD54 (ICAM1) and major histocompatibility complex class I antigens by nuclear factor kappaB in HEp2 tumor cell line: effect on the function of natural killer cells.

  2003cited by this paper
• Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor.

  2003cited by this paper
• A mouse model of human oral-esophageal cancer.

  2002cited by this paper
• Resolution of oral non-Hodgkin's lymphoma by reduction of immunosuppressive therapy in a renal allograft recipient: a case report and review of the literature.

  2002cited by this paper
• Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells

  2002cited by this paper
• The two faces of IL-6 on Th1/Th2 differentiation.

  2002cited by this paper
• Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer.

  2002cited by this paper
• Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology.

  2002cited by this paper
• Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers

  2002cited by this paper
• Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4

  2002cited by this paper
• TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2

  2002cited by this paper
• Cancer immunoediting: from immunosurveillance to tumor escape

  2002cited by this paper
• NF-kappaB in cancer: from innocent bystander to major culprit.

  2002cited by this paper
• Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.

  2002cited by this paper
• The biology of human natural killer-cell subsets.

  2001cited by this paper
• Solid cancers after bone marrow transplantation.

  2001cited by this paper
• IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity

  2001cited by this paper
• Follicular Lymphoma of the Salivary Gland

  2001cited by this paper
• MHC-Class I antigens regulate both the function and the survival of human peripheral blood NK cells: role of endogenously secreted TNF-alpha.

  2000cited by this paper
• Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling.

  1999cited by this paper
• Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity.

  1999cited by this paper
• Aberrant rel/nfkb genes and activity in human cancer

  1999cited by this paper
• Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer.

  1999cited by this paper
• Spectrum of AIDS-associated malignant disorders.

  1998cited by this paper
• The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.

  1998cited by this paper
• Breast cancer: poor short-term prognosis in cases with moderate lymphocyte infiltration at the tumour edge: a preliminary report.

  1998cited by this paper
• Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration

  1998cited by this paper
• Carcinoma of the lip in kidney transplant recipients.

  1998cited by this paper
• Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor.

  1998cited by this paper
• Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo.

  1998cited by this paper
• Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB.

  1998cited by this paper
• Tumor lymphocytes in patients with advanced ovarian cancer: changes during in vitro culture and implications for immunotherapy.

  1997cited by this paper
• Isolation and Characterization of LPS Mutants of Actinobacillus pleuropneumoniae Serotype 1

  1997cited by this paper
• Pivotal role of endogenous TNF-alpha in the induction of functional inactivation and apoptosis in NK cells.

  1997cited by this paper
• Study of tumor infiltrating lymphocytes and transforming growth factor‐β as prognostic factors in breast carcinoma

  1997cited by this paper
• NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor

  1997cited by this paper
• Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas.

  1997cited by this paper
• The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma

  1997cited by this paper
• Squamous cell carcinoma of the lower lip in renal-transplant recipients. Report of six cases.

  1997cited by this paper
• T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma.

  1997cited by this paper
• CD27/CD70 interaction directly induces natural killer cell killing activity

  1996cited by this paper
• Target-induced inactivation and cell death by apoptosis in a subset of human NK cells.

  1996cited by this paper
• Infiltration By Immunocompetent Cells In Early Stage Invasive Carcinoma Of The Uterine Cervix: A prognostic study

  1996cited by this paper
• Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma

  1996cited by this paper
• Breast cancer–associated antigen, DF3/MUC1, induces apoptosis of activated human T cells

  1996cited by this paper
• Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits.

  1996cited by this paper
• Antitumor effects of cytolytic T lymphocytes (CTL) and natural killer (NK) cells in head and neck cancer.

  1996cited by this paper
• Differential secretion of TNF-alpha and IFN-gamma by human peripheral blood-derived NK subsets and association with functional maturation.

  1996cited by this paper
• In situ cytokine production by breast cancer tumor-infiltrating lymphocytes

  1996cited by this paper
• Limiting dilution analysis of proliferating and cytotoxic lymphocytes in the peripheral blood and tumours of oral cancer patients.

  1996cited by this paper
• Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.

  1996cited by this paper
• Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes.

  1995cited by this paper
• Inflammatory cell infiltrate associated with primary and transplanted tumours in an inbred model of oral carcinogenesis.

  1995cited by this paper
• Target-induced anergy of natural killer cytotoxic function is restricted to the NK-target conjugate subset.

  1995cited by this paper
• Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity.

  1995cited by this paper
• Increased prevalence of dysplastic and malignant lip lesions in renal-transplant recipients.

  1995cited by this paper
• Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer.

  1995cited by this paper
• Ligand binding to Fc gamma R induces c-myc-dependent apoptosis in IL-2-stimulated NK cells.

  1995cited by this paper
• Receptor-induced death in human natural killer cells: involvement of CD16

  1995cited by this paper
• Interferon-alpha activates cytotoxic function but inhibits interleukin-2-mediated proliferation and tumor necrosis factor-alpha secretion by immature human natural killer cells.

  1995cited by this paper
• Nonsteroidal anti-inflammatory drugs differentially regulate cytokine production in human lymphocytes: up-regulation of TNF, IFN-gamma and IL-2, in contrast to down-regulation of IL-6 production.

  1995cited by this paper
• Activation of the human immature natural killer cell subset by IL-12 and its regulation by endogenous TNF-alpha and IFN-gamma secretion.

  1994cited by this paper
• Qualitative and quantitative analysis of subpopulations of cytotoxic effector cells by flow cytometry.

  1994cited by this paper
• Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma.

  1993cited by this paper
• Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.

  1993cited by this paper
• Natural killer cell subsets: maturation, differentiation and regulation.

  1993cited by this paper
• In vivo interleukin 2-induced activation of lymphokine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumors.

  1990cited by this paper
• Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of lnterleukin‐2 injected periiymphatically

  1988cited by this paper

• Cancer Stem Cells Connecting to Immunotherapy: Key Insights, Challenges, and Potential Treatment Opportunities

  2025cites this paper
• Colorectal cancer stem cells crosstalk in tumor immune microenvironment and targeted therapeutic strategies

  2025cites this paper
• Biomedical engineering targeting cancer stem cells to reinforce cancer therapy

  2025cites this paper
• A Critical Role of Culture Medium Selection in Maximizing the Purity and Expansion of Natural Killer Cells

  2024cites this paper
• NK cell based immunotherapy against oral squamous cell carcinoma

  2024cites this paper
• Circulating tumor cells: from new biological insights to clinical practice

  2024cites this paper
• Cysteine Cathepsins as Therapeutic Targets in Immune Regulation and Immune Disorders

  2023cites this paper
• Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment

  2023cites this paper
• Characterizing hepatocellular carcinoma stem markers and their corresponding susceptibility to NK-cell based immunotherapy

  2023cites this paper
• Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective

  2023cites this paper
• The Potential Role of Cytotoxic Immune Effectors in Amyotrophic Lateral Sclerosis (ALS); A Longitudinal Case Study Comparing Patients with Genetically Identical Healthy Twin.

  2023cites this paper
• Zoledronic acid mediated differential activation of NK cells in different organs of WT and Rag2-/- mice; stark differences between the bone marrow and gingivae.

  2022cites this paper
• Synthetic cannabinoid WIN 55,212–2 inhibits growth and induces cell death of oral and pancreatic stem-like/poorly differentiated tumor cells

  2022cites this paper
• Defective Patient NK Function Is Reversed by AJ2 Probiotic Bacteria or Addition of Allogeneic Healthy Monocytes

  2022cites this paper
• Engaging stemness improves cancer immunotherapy.

  2022cites this paper
• Inflammation and Limb Regeneration: The Role of the Chemokines

  2022cites this paper
• Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy

  2022cites this paper
• Mechanisms of immune evasion by head and neck cancer stem cells

  2022cites this paper
• The Molecular Basis of Different Approaches for the Study of Cancer Stem Cells and the Advantages and Disadvantages of a Three-Dimensional Culture

  2021cites this paper
• Phenotypic and Functional Alterations of Immune Effectors in Periodontitis; A Multifactorial and Complex Oral Disease

  2021cites this paper
• Immune evasion by cancer stem cells

  2021cites this paper
• Cancer Stem Cells Are Possible Key Players in Regulating Anti-Tumor Immune Responses: The Role of Immunomodulating Molecules and MicroRNAs

  2021cites this paper
• Long Non-Coding RNAs (lncRNAs) in Response and Resistance to Cancer Immunosurveillance and Immunotherapy

  2021cites this paper
• Amalgamation of Stem Cells with Nanotechnology: A Unique Therapeutic Approach.

  2019cites this paper
• Interactions between cancer stem cells, immune system and some environmental components: Friends or foes?

  2019cites this paper
• The 14q32.31 DLK1-DIO3 MIR300 tumor suppressor promotes leukemogenesis by inducing cancer stem cell quiescence and inhibiting NK cell anti-cancer immunity

  2019cites this paper
• Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche

  2019cites this paper
• Functional recovery of natural killer cell activity by nanoparticle‐mediated delivery of transforming growth factor beta 2 small interfering RNA

  2019cites this paper
• Characterization of the Cellular Responses of Dental Mesenchymal Stem Cells to the Immune System

  2018cites this paper
• Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells

  2018cites this paper
• Cyclin-Dependent Kinase 8: A New Hope in Targeted Cancer Therapy?

  2018cites this paper
• Activated human primary NK cells efficiently kill colorectal cancer cells in 3D spheroid cultures irrespectively of the level of PD-L1 expression

  2018cites this paper
• Monocyte/Macrophage: NK Cell Cooperation-Old Tools for New Functions.

  2017cites this paper
• Correlation of cancer stem cell markers and immune cell markers in resected non-small cell lung cancer

  2017cites this paper
• Whole genome gene expression changes and hematological effects of rikkunshito in patients with advanced non-small cell lung cancer receiving first line chemotherapy

  2017cites this paper
• Differentiation by NK cells is a prerequisite for effective targeting of cancer stem cells/poorly differentiated tumors by chemopreventive and chemotherapeutic drugs

  2017cites this paper
• Rat embryonic fibroblasts immortalized by MRPS18-2 protein are target for NK-cells

  2017cites this paper
• Lidocaine Stimulates the Function of Natural Killer Cells in Different Experimental Settings.

  2017cites this paper
• Cancer Is the Innate Immunity Fault

  2017cites this paper
• Hide-and-seek: the interplay between cancer stem cells and the immune system

  2017cites this paper
• Expansion of cytotoxic natural killer cells using irradiated autologous peripheral blood mononuclear cells and anti-CD16 antibody

  2017cites this paper
• Global dynamics of a colorectal cancer treatment model with cancer stem cells

  2017cites this paper
• Novel strategies to target cancer stem cells by NK cells; studies in humanized mice.

  2017cites this paper
• Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia Cells

  2016cites this paper
• Malignant Pleural Effusion and ascites Induce Epithelial-Mesenchymal Transition and Cancer Stem-like Cell Properties via the Vascular Endothelial Growth Factor (VEGF)/Phosphatidylinositol 3-Kinase (PI3K)/Akt/Mechanistic Target of Rapamycin (mTOR) Pathway*

  2016cites this paper
• Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells

  2016cites this paper
• Cancer stem cell targets - a review.

  2016cites this paper
• The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applications.

  2016influential citation
• Developing a universal T cell for use in adoptive immunotherapy

  2015cites this paper
• Split anergized natural killer cells halt inflammation by inducing stem cell differentiation, resistance to NK cell cytotoxicity and prevention of cytokine and chemokine secretion

  2015influential citation
• Cancer and cancer stem cell targeting agents : A focus on salinomycin and apoptin

  2015cites this paper
• Augmented IFN-γ and TNF-α Induced by Probiotic Bacteria in NK Cells Mediate Differentiation of Stem-Like Tumors Leading to Inhibition of Tumor Growth and Reduction in Inflammatory Cytokine Release; Regulation by IL-10

  2015cites this paper
• What Tumor Dynamics Modeling Can Teach us About Exploiting the Stem-Cell View for Better Cancer Treatment

  2015cites this paper
• Targeting Head and Neck Cancer Stem Cells

  2015cites this paper
• Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent manner.

  2015cites this paper
• Differential Targeting of Stem Cells and Differentiated Glioblastomas by NK Cells

  2015cites this paper
• Differential Cytotoxicity but Augmented IFN-γ Secretion by NK Cells after Interaction with Monocytes from Humans, and Those from Wild Type and Myeloid-Specific COX-2 Knockout Mice

  2015cites this paper
• Role of Osteoclasts in the potential pathogenic mechanism of Osteonecrosis of Jaw

  2015cites this paper
• Impact of chemotherapeutics drugs in NK-mediated killing by over expression of death receptors on cancer cells

  2015cites this paper
• Immunologic Approaches to Targeting Cancer Stem Cells

  2015cites this paper
• Resistance of Cancer Stem Cells to Cell-Mediated Immune Responses

  2015cites this paper
• Role of Osteoclasts in the potential pathogenic mechanism of Osteonecrosis of Jaw

  2015cites this paper
• Role of Osteoclasts in potential pathogenic mechnism of ONJ

  2015cites this paper
• Cancer Immunology and Immunodeficiency TUMOR

  2015cites this paper
• Scar-free wound healing and regeneration in amphibians: immunological influences on regenerative success.

  2014cites this paper
• Melatonin and Immune Function: Clinical Significance

  2014cites this paper
• Cancer stem cells: perspectives for therapeutic targeting

  2014cites this paper
• The promise of perfect adult tissue repair and regeneration in mammals: Learning from regenerative amphibians and fish

  2014cites this paper
• Bacteria Induced Split Anergy in NK Cells Drive Maturation, Differentiation and Resistance of Healthy and Transformed Stem Cells

  2014cites this paper
• Induction of Split Anergy Conditions Natural Killer Cells to Promote Differentiation of Stem Cells through Cell–Cell Contact and Secreted Factors

  2014cites this paper
• Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective

  2014cites this paper
• STAT1-S727 - the license to kill

  2014cites this paper
• Strategies for Isolating and Enriching Cancer Stem Cells: Well Begun Is Half Done

  2013cites this paper
• Cancer Stem Cells Provide New Insights into the Therapeutic Responses of Human Prostate Cancer

  2013cites this paper
• Natural Cytotoxicity Receptors and MHC Initiating Cells : A Role for − Colon Cancer Human NK Cells Selective Targeting of Dieli

  2013cites this paper
• Advantages and clinical applications of natural killer cells in cancer immunotherapy

  2013cites this paper
• Human NK Cells Selective Targeting of Colon Cancer–Initiating Cells: A Role for Natural Cytotoxicity Receptors and MHC Class I Molecules

  2013cites this paper
• Tumor-Infiltrating Immune Cells Promoting Tumor Invasion and Metastasis: Existing Theories

  2013cites this paper
• Proceedings of the Annual Symposium & Plenary Session on Regenerative Medicine (PASRM)

  2013cites this paper
• The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients

  2013cites this paper
• CTLA-4 Blockade Expands Infiltrating T Cells and Inhibits Cancer Cell Repopulation during the Intervals of Chemotherapy in Murine Mesothelioma

  2012cites this paper
• Natural killer cells in non-hematopoietic malignancies

  2012cites this paper
• Preclinical Development CTLA-4 Blockade Expands In fi ltrating T Cells and Inhibits Cancer Cell Repopulation during the Intervals of Chemotherapy in Murine Mesothelioma

  2012cites this paper
• Bacterial Lipopolysaccharides Induce Suppression of Natural Killer Cell Function

  2012influential citation